Hutch News

Hutch News

Stories tagged 'John Pagel'

Radiolabeled antibodies, transplant successfully treat advanced leukemia

John Pagel’s research offers hope with novel treatment combination for older patients

Nov. 9, 2009 | By Dean Forbes

For the first time, Fred Hutchinson Cancer Research Center Clinical Research Division investigators used a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. Results of the study, led by Dr. John Pagel, appeared online Sept. 28 in the journal Blood.

View story >


Gopal, Pagel present AML, MDS findings at annual ASH meeting

Dec. 15, 2005

View story >


Triple-threat academic on board

John Pagel steps up to the challenge of developing and improving antibody therapies for lymphoma, leukemia patients

Sept. 15, 2005 | By CHRISTINE LOFTUS

View story >


Partners in research pathology

Research Pathology's Experimental Histopathology, Solid Tumor sections aid in design, development, interpretation of studies involving tissue samples

Nov. 18, 2004 | By BARBARA BERG

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.